Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beraprost vs Sildenafil in Pediatric PAH with Left-to-Right Shunt
NCT03431649Phase 4Completed
- Sponsor
- Dr. Soetomo General Hospital
- Start
- Apr 2017
- Primary completion
- Jul 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of beraprost in pulmonary arterial hypertension (PAH) (2 arms), sponsored by Dr. Soetomo General Hospital. Primary endpoint: Pulmonary Arterial Pressure at 12 weeks. Started Apr 2017; status: completed.
02
Drugs
beraprost
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT03431649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03431649.